Therabron
Rockville · Founded 2007
About Therabron
Therabron Therapeutics, we are working to change how respiratory diseases are managed. We are aiming to not only provide symptomatic relief, but also to improve long-term health outcomes and reduce healthcare costs. A privately held, clinical-stage, biopharmaceutical corporation, Therabron is developing a new class of drugs from the secretoglobin family of proteins. Our lead product, recombinant human CC10 protein (rhCC10), is a potent anti-inflammatory agent for patients with respiratory diseases.
Company Facts
- Founded: 2007
- Legal name: Therabron Therapeutics, Inc.
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $17.9M
- Funding stage: Early Stage Venture
- Last round: Debt Financing (Dec 2016)
- Website: therabron.com
- Phone: (240) 205-7271
Social Profiles
Canonical: https://fsome.com/organization/therabron-8294118 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.